| Indicators | Browse All

Aclarion, Inc. (ACON)

Healthcare | Health Information Services | Broomfield, United States | NasdaqCM
2.69 USD -0.15 (-5.415%) ⇩ (July 13, 2026, 4 p.m. EDT)
After hours: 2.69

Short-term:★☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 4 a.m. EDT

The immediate outlook is severely clouded by a massive disconnect between the current trading price and the company's book value, suggesting a deep liquidity crisis rather than a standard market correction. While the recent price action shows some volatility near resistance, the underlying reality is stark: the stock trades at less than 36 cents on the dollar relative to its assets, a condition rarely compatible with sustainable operations. This valuation gap is compounded by a complete absence of profitability, with negative earnings per share and operating margins that are mathematically impossible to sustain without capital infusion. The recent news of a buyback plan and an acquisition proposal highlights the desperation of the situation; management is attempting to engineer value through capital returns and strategic pivots, but these moves cannot mask the fact that the business is burning cash and missing revenue targets. Furthermore, the multi-year price trajectory tells a story of total destruction, with the asset losing nearly 100% of its value over the last three years. This is not a temporary setback but a structural implosion where the market has priced out any expectation of recovery. With no dividend to provide income and a statistical forecast model indicating very low reliability due to the extreme price noise, there is no rational basis for a bullish stance. The security represents a high-risk speculative play on a potential turnaround that requires significant external validation beyond the current data.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.208404
MSTL_1170.251997
MSTL0.348806
AutoETS0.365123
AutoARIMA0.376649

Forecast horizon: 60 days | Selected: AutoTheta

Forecast Reliability
Score 28%
H-stat 5.16
Ljung-Box p 0.000
Jarque-Bera p 0.285
Excess Kurtosis -1.00
Attribute Value
Sector Healthcare
Revenue per Share 0.077
Market Cap 6,623,452
Forward P/E -0.49
Beta 1.21
Website https://www.aclarion.com

Info Dump

Attribute Value
52 Week Change -0.6120055
Address1 8,181 Arista Place
Address2 Suite 100
All Time High 586,116.0
All Time Low 2.34
Ask 2.74
Ask Size 1
Average Daily Volume10 Day 32,810
Average Daily Volume3 Month 92,447
Average Volume 92,447
Average Volume10Days 32,810
Beta 1.206
Bid 2.65
Bid Size 1
Book Value 8.039
City Broomfield
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 2.69
Current Ratio 19.648
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 2.8799
Day Low 2.63
Display Name Aclarion
Ebitda -8,314,259
Ebitda Margins 0.0
Enterprise To Ebitda 1.49
Enterprise To Revenue -159.113
Enterprise Value -12,391,524
Eps Current Year -4.51
Eps Forward -5.47
Eps Trailing Twelve Months -5.33
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 3.14928
Fifty Day Average Change -0.45928
Fifty Day Average Change Percent -0.14583652
Fifty Two Week Change Percent -61.200546
Fifty Two Week High 12.03
Fifty Two Week High Change -9.34
Fifty Two Week High Change Percent -0.7763924
Fifty Two Week Low 2.34
Fifty Two Week Low Change 0.35000014
Fifty Two Week Low Change Percent 0.14957272
Fifty Two Week Range 2.34 - 12.03
Financial Currency USD
First Trade Date Milliseconds 1,650,634,200,000
Float Shares 2,202,163
Forward Eps -5.47
Forward P E -0.49177334
Free Cashflow -4,897,093
Full Exchange Name NasdaqCM
Full Time Employees 10
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.19344999
Gross Profits 15,066
Has Pre Post Market Data 1
Held Percent Insiders 0.26198998
Held Percent Institutions 0.043520004
Implied Shares Outstanding 2,462,250
Industry Health Information Services
Industry Disp Health Information Services
Industry Key health-information-services
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,743,120,000
Last Split Factor 1:27
Long Business Summary Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam; and imaging data transfer products, including AMBRA Healthcare, a data transfer platform. In addition, the company offers The NOCISCAN Post-Processor Suite comprising NOCICALC, a Class I medical device that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra, and performs various degenerative pain biomarker calculations from those spectra, for each disc examined; and NOCIGRAM, which further processes the NOCICALC results into individual NOCISCORES, on a 0-10 scale, that represent the different relative levels of degenerative pain biomarkers the various discs examined in the patient. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Long Name Aclarion, Inc.
Market us_market
Market Cap 6,623,452
Market State PREPRE
Max Age 86,400
Message Board Id finmb_108179695
Most Recent Quarter 1,774,915,200
Net Income To Common -8,049,768
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 7,002,639
Number Of Analyst Opinions 1
Open 2.81
Operating Cashflow -7,295,267
Operating Margins -141.29333
Payout Ratio 0.0
Phone 833 275 2266
Post Market Change 0.0
Post Market Change Percent 0.0
Post Market Price 2.69
Post Market Time 1,783,983,086
Previous Close 2.844
Price Eps Current Year -0.5964523
Price Hint 4
Price To Book 0.33461875
Price To Sales Trailing12 Months 85.04798
Profit Margins 0.0
Quick Ratio 19.322
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.154
Regular Market Change Percent -5.41491
Regular Market Day High 2.8799
Regular Market Day Low 2.63
Regular Market Day Range 2.63 - 2.8799
Regular Market Open 2.81
Regular Market Previous Close 2.844
Regular Market Price 2.69
Regular Market Time 1,783,972,801
Regular Market Volume 61,034
Return On Assets -0.28783
Return On Equity -0.45433998
Revenue Growth 0.113
Revenue Per Share 0.077
Sand P52 Week Change 0.20847368
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 2,462,250
Shares Percent Shares Out 0.0222
Shares Short 54,618
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 180,125
Short Name Aclarion, Inc.
Short Percent Of Float 0.0222
Short Ratio 0.7
Source Interval 15
State CO
Symbol ACON
Target High Price 7.5
Target Low Price 7.5
Target Mean Price 7.5
Target Median Price 7.5
Total Cash 19,014,976
Total Cash Per Share 7.723
Total Debt 0
Total Revenue 77,879
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -5.33
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 4.60961
Two Hundred Day Average Change -1.91961
Two Hundred Day Average Change Percent -0.41643652
Type Disp Equity
Volume 61,034
Website https://www.aclarion.com
Zip 80,021